IN2013MU03843A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MU03843A IN2013MU03843A IN3843MU2013A IN2013MU03843A IN 2013MU03843 A IN2013MU03843 A IN 2013MU03843A IN 3843MU2013 A IN3843MU2013 A IN 3843MU2013A IN 2013MU03843 A IN2013MU03843 A IN 2013MU03843A
- Authority
- IN
- India
- Prior art keywords
- benzyl
- methylpiperidin
- methylamine
- methanol
- pyridine
- Prior art date
Links
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract 6
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 abstract 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 2
- NVKDDQBZODSEIN-OCCSQVGLSA-N (3r,4r)-1-benzyl-n,4-dimethylpiperidin-3-amine Chemical compound C1C[C@@H](C)[C@@H](NC)CN1CC1=CC=CC=C1 NVKDDQBZODSEIN-OCCSQVGLSA-N 0.000 abstract 1
- IBKMZYWDWWIWEL-UHFFFAOYSA-N 4-methylpyridin-3-amine Chemical compound CC1=CC=NC=C1N IBKMZYWDWWIWEL-UHFFFAOYSA-N 0.000 abstract 1
- 230000006181 N-acylation Effects 0.000 abstract 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- -1 benzyl halide Chemical class 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- WRPYDRDMRXJIJA-UHFFFAOYSA-N n-(4-methylpyridin-3-yl)acetamide Chemical compound CC(=O)NC1=CN=CC=C1C WRPYDRDMRXJIJA-UHFFFAOYSA-N 0.000 abstract 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 1
- 238000006722 reduction reaction Methods 0.000 abstract 1
- 238000006268 reductive amination reaction Methods 0.000 abstract 1
- 230000002829 reductive effect Effects 0.000 abstract 1
- 229910000033 sodium borohydride Inorganic materials 0.000 abstract 1
- 239000012279 sodium borohydride Substances 0.000 abstract 1
- 235000002906 tartaric acid Nutrition 0.000 abstract 1
- 239000011975 tartaric acid Substances 0.000 abstract 1
- VXUYXOFXAQZZMF-UHFFFAOYSA-N titanium(IV) isopropoxide Chemical compound CC(C)O[Ti](OC(C)C)(OC(C)C)OC(C)C VXUYXOFXAQZZMF-UHFFFAOYSA-N 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/02—Preparation by ring-closure or hydrogenation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/98—Nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Priority Applications (23)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES14869304T ES2720066T3 (es) | 2013-12-09 | 2014-12-02 | Mejora del proceso de preparación de (3R,4R)-(1-bencil-4-metilpiperidín-3-il)-metilamina |
HUE19150972A HUE053975T2 (hu) | 2013-12-09 | 2014-12-02 | Továbbfejlesztett eljárás (3R,4R)-(1-benzil-4-metilpiperidin-3-il)-metilamin elõállítására |
PCT/IB2014/066510 WO2015087201A1 (en) | 2013-12-09 | 2014-12-02 | An improved process for the preparation of (3r,4r)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine |
EP14869304.7A EP2994454B1 (en) | 2013-12-09 | 2014-12-02 | An improved process for the preparation of (3r,4r)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine |
TR2019/04767T TR201904767T4 (tr) | 2013-12-09 | 2014-12-02 | (3R,4R)-(1-benzil-4-metilpiperidin-3-il)-metilamin hazırlanması için geliştirilmiş bir işlem. |
SI201431805T SI3539965T1 (sl) | 2013-12-09 | 2014-12-02 | Izboljšan postopek za pripravo (3R,4R)-(1-benzil-4-metilpiperidin-3-il)-metilamina |
ES19150972T ES2865058T3 (es) | 2013-12-09 | 2014-12-02 | Un proceso mejorado para la preparación de (3R,4R)-(1-bencil-4-metilpiperidin-3-il)-metilamina |
PL14869304T PL2994454T3 (pl) | 2013-12-09 | 2014-12-02 | Ulepszony sposób wytwarzania (3R,4R)-(1-benzylo-4-metylopiperydyn-3-ylo)metyloaminy |
EP19150972.8A EP3539965B1 (en) | 2013-12-09 | 2014-12-02 | An improved process for the preparation of (3r,4r)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine |
MX2015015432A MX362290B (es) | 2013-12-09 | 2014-12-02 | Un proceso mejorado para la preparacion de (3r,4r)-(1-bencilo-4-me tilpiperidina-3-il)-metilamina. |
PT14869304T PT2994454T (pt) | 2013-12-09 | 2014-12-02 | Um processo melhorado para a preparacao de (3r,4r)-(1-benzil-4- metilpiperidin-3-il)-metilamina |
JP2016557204A JP6368794B2 (ja) | 2013-12-09 | 2014-12-02 | (3r,4r)−(1−ベンジル−4−メチルピペリジン−3−イル)−メチルアミンの改良された調製方法 |
PT191509728T PT3539965T (pt) | 2013-12-09 | 2014-12-02 | Processo melhorado para a preparação de (3r,4r)-(1-benzil-4-metilpiperidin-3-il)-metilamina |
BR112015025543-4A BR112015025543B1 (pt) | 2013-12-09 | 2014-12-02 | processo para a preparação de (3r,4r)-(1-benzil-4- metilpiperidina-3-il)-metilamina e compostos intermediários |
PL19150972T PL3539965T3 (pl) | 2013-12-09 | 2014-12-02 | Ulepszony sposób wytwarzania (3r,4r)-(1-benzylo-4-mety-lopiperydyn-3-ylo)metyloaminy |
US14/891,028 US9951012B2 (en) | 2013-12-09 | 2014-12-02 | Process for the preparation of (3R,4R)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine |
IN3843MU2013 IN2013MU03843A (enrdf_load_html_response) | 2013-12-09 | 2014-12-02 | |
SI201431159T SI2994454T1 (sl) | 2013-12-09 | 2014-12-02 | Izboljšan postopek za pripravo (3R,4R)-(1-benzil-4-metil piperidin-3-il)-metil amina |
HUE14869304A HUE042911T2 (hu) | 2013-12-09 | 2014-12-02 | Javított eljárás a (3R,4R)-(1-benzil-4-metil-piperidin-3-il)-metilamin elõállítására |
ZA2015/06551A ZA201506551B (en) | 2013-12-09 | 2015-09-04 | An improved process for the preparation of (3r,4r)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine |
US15/590,408 US20170240510A1 (en) | 2013-12-09 | 2017-05-09 | Process for the preparation of (3r,4r)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine |
US15/786,195 US20180037551A1 (en) | 2013-12-09 | 2017-10-17 | Process for the Preparation of (3R,4R)-(1-BENZYL-4-METHYLPIPERIDIN-3-YL)-METHYLAMINE |
US15/868,331 US10829450B2 (en) | 2013-12-09 | 2018-01-11 | Process for the preparation of (3R,4R)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3843MU2013 IN2013MU03843A (enrdf_load_html_response) | 2013-12-09 | 2014-12-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2013MU03843A true IN2013MU03843A (enrdf_load_html_response) | 2015-08-14 |
Family
ID=53370688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN3843MU2013 IN2013MU03843A (enrdf_load_html_response) | 2013-12-09 | 2014-12-02 |
Country Status (14)
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN2013MU03843A (enrdf_load_html_response) * | 2013-12-09 | 2015-08-14 | Unichem Lab Ltd | |
ES2962330T3 (es) | 2015-01-20 | 2024-03-18 | Wuxi Fortune Pharmaceutical Co Ltd | Inhibidor de jak |
MX370933B (es) | 2015-04-29 | 2020-01-09 | Wuxi Fortune Pharmaceuticals Co Ltd | Inhibidores jak. |
CA2983481C (en) | 2015-05-29 | 2020-04-14 | Wuxi Fortune Pharmaceutical Co., Ltd | Janus kinase inhibitor |
CN105237463B (zh) * | 2015-10-09 | 2017-10-10 | 刘卫国 | 一种(3r,4r)‑(1‑苄基‑4‑甲基哌啶‑3‑基)甲胺‑l‑二对甲苯甲酰酒石酸盐的制备方法 |
CN105884781B (zh) * | 2016-04-18 | 2018-04-20 | 山东罗欣药业集团股份有限公司 | 一种枸橼酸托法替布的制备方法 |
EP3301087A1 (en) * | 2016-09-30 | 2018-04-04 | DPx Fine Chemicals Austria GmbH & Co KG | Process for preparing chiral amines |
CN107056681B (zh) * | 2017-03-30 | 2019-10-01 | 广州白云山光华制药股份有限公司 | 一种托法替布中间体的制备方法 |
CN110668995A (zh) * | 2018-07-03 | 2020-01-10 | 江苏海悦康医药科技有限公司 | 一种枸橼酸托法替布中间体及枸橼酸托法替布的制备方法 |
CN112645866B (zh) * | 2020-12-22 | 2024-03-22 | 浙江奥翔药业股份有限公司 | 1-苄基-4-甲基-5-烷氧基-1,2,3,6-四氢吡啶衍生物的合成及应用 |
CN114685515A (zh) * | 2022-03-15 | 2022-07-01 | 上海蓝乐鸟实业有限公司 | 一种托法替尼的制备方法 |
CN115872923B (zh) * | 2022-12-29 | 2023-04-28 | 成都泰和伟业生物科技有限公司 | 一种化合物及其制备方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06145144A (ja) | 1992-11-04 | 1994-05-24 | Ihara Chem Ind Co Ltd | 新規な3−アミノピリジン誘導体第4級アンモニウム塩及びこれを有効成分とする抗癌剤 |
JP4671079B2 (ja) * | 1999-07-05 | 2011-04-13 | 日本農薬株式会社 | フタラミド誘導体、その中間体及び農園芸用殺虫剤並びにその使用方法 |
NZ518369A (en) * | 1999-10-20 | 2003-09-26 | Tanabe Seiyaku Co | 1,3 or 1,8-Diazabicyclo octane or nonane derivatives or tricyclic derivatives useful as inhibitors of alphaL-beta2 mediated cell adhesion |
NZ528905A (en) * | 1999-12-10 | 2005-03-24 | Pfizer Prod Inc | Pyrrolo[2,3-d]pyrimidine compounds |
EA007485B1 (ru) | 2001-02-24 | 2006-10-27 | Берингер Ингельхайм Фарма Гмбх Унд Ко. Кг | Производные ксантина, способ их получения, фармацевтическая композиция на их основе и способ ее получения |
US7301023B2 (en) * | 2001-05-31 | 2007-11-27 | Pfizer Inc. | Chiral salt resolution |
GT200200234A (es) * | 2001-12-06 | 2003-06-27 | Compuestos cristalinos novedosos | |
UY29300A1 (es) * | 2004-12-22 | 2006-07-31 | Astrazeneca Ab | Compuestos quimicos |
PT1913000E (pt) * | 2005-07-29 | 2012-02-28 | Pfizer Prod Inc | Derivados de pirrolo[2,3-d]pirimidina, suas substâncias intermédias e processo de síntese |
WO2008029237A2 (en) * | 2006-09-05 | 2008-03-13 | Pfizer Products Inc. | Combination therapies for rheumatoid arthritis |
MX2011001259A (es) * | 2008-08-01 | 2011-03-15 | Biocryst Pharm Inc | Derivados de piperidina como inhibidores jak3. |
TW201102389A (en) | 2009-04-14 | 2011-01-16 | Astellas Pharma Inc | Fused pyrroloprydine derivatives |
CN102459270B (zh) | 2009-04-20 | 2015-04-29 | 奥斯拜客斯制药有限公司 | Janus激酶3的哌啶抑制剂 |
JP5789603B2 (ja) * | 2009-07-21 | 2015-10-07 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | ヘテロアリールベンズアミド、組成物および使用の方法 |
MX2012003778A (es) * | 2009-09-29 | 2012-06-01 | Glaxo Group Ltd | Compuestos novedosos. |
IN2013MU03843A (enrdf_load_html_response) * | 2013-12-09 | 2015-08-14 | Unichem Lab Ltd |
-
2014
- 2014-12-02 IN IN3843MU2013 patent/IN2013MU03843A/en unknown
- 2014-12-02 PT PT191509728T patent/PT3539965T/pt unknown
- 2014-12-02 HU HUE19150972A patent/HUE053975T2/hu unknown
- 2014-12-02 US US14/891,028 patent/US9951012B2/en active Active
- 2014-12-02 PL PL19150972T patent/PL3539965T3/pl unknown
- 2014-12-02 EP EP14869304.7A patent/EP2994454B1/en active Active
- 2014-12-02 SI SI201431805T patent/SI3539965T1/sl unknown
- 2014-12-02 MX MX2015015432A patent/MX362290B/es active IP Right Grant
- 2014-12-02 JP JP2016557204A patent/JP6368794B2/ja not_active Expired - Fee Related
- 2014-12-02 HU HUE14869304A patent/HUE042911T2/hu unknown
- 2014-12-02 SI SI201431159T patent/SI2994454T1/sl unknown
- 2014-12-02 PT PT14869304T patent/PT2994454T/pt unknown
- 2014-12-02 WO PCT/IB2014/066510 patent/WO2015087201A1/en active Application Filing
- 2014-12-02 ES ES14869304T patent/ES2720066T3/es active Active
- 2014-12-02 ES ES19150972T patent/ES2865058T3/es active Active
- 2014-12-02 TR TR2019/04767T patent/TR201904767T4/tr unknown
- 2014-12-02 BR BR112015025543-4A patent/BR112015025543B1/pt not_active IP Right Cessation
- 2014-12-02 EP EP19150972.8A patent/EP3539965B1/en active Active
- 2014-12-02 PL PL14869304T patent/PL2994454T3/pl unknown
-
2015
- 2015-09-04 ZA ZA2015/06551A patent/ZA201506551B/en unknown
-
2017
- 2017-05-09 US US15/590,408 patent/US20170240510A1/en not_active Abandoned
- 2017-10-17 US US15/786,195 patent/US20180037551A1/en not_active Abandoned
-
2018
- 2018-01-11 US US15/868,331 patent/US10829450B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2015087201A1 (en) | 2015-06-18 |
ES2865058T3 (es) | 2021-10-14 |
SI3539965T1 (sl) | 2021-07-30 |
PL2994454T3 (pl) | 2019-09-30 |
MX2015015432A (es) | 2016-03-15 |
BR112015025543A2 (pt) | 2017-07-18 |
ZA201506551B (en) | 2017-02-22 |
EP2994454A4 (en) | 2016-12-21 |
US20160102057A1 (en) | 2016-04-14 |
BR112015025543B1 (pt) | 2020-11-03 |
EP3539965B1 (en) | 2021-01-20 |
US20180134661A1 (en) | 2018-05-17 |
HUE042911T2 (hu) | 2019-07-29 |
US20170240510A1 (en) | 2017-08-24 |
JP6368794B2 (ja) | 2018-08-01 |
PL3539965T3 (pl) | 2021-07-05 |
US9951012B2 (en) | 2018-04-24 |
EP3539965A1 (en) | 2019-09-18 |
PT3539965T (pt) | 2021-04-07 |
PT2994454T (pt) | 2019-04-02 |
ES2720066T3 (es) | 2019-07-17 |
EP2994454A1 (en) | 2016-03-16 |
MX362290B (es) | 2019-01-10 |
US10829450B2 (en) | 2020-11-10 |
JP2017503007A (ja) | 2017-01-26 |
US20180037551A1 (en) | 2018-02-08 |
TR201904767T4 (tr) | 2019-05-21 |
EP2994454B1 (en) | 2019-03-06 |
HUE053975T2 (hu) | 2021-08-30 |
SI2994454T1 (sl) | 2019-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2013MU03843A (enrdf_load_html_response) | ||
MY156546A (en) | Process for the regioselective preparation of 1-alkyl-3-haloalkylpyrazole-4-carboxylic acid derivatives | |
MY201120A (en) | Intermediates for use in a process of producing pyrrole compounds | |
MX2010009003A (es) | Ciclohexanodimetanamina por aminacion directa de ciclohexanodimetanol. | |
JOP20160185B1 (ar) | طريقة لتحضير (4s)-4-(4- سيانو-2- ميثوكسي فنيل)-5- إيثوكسي-8،2-داي ميثيل-4،1-داي هيدرو-6،1- نافثيريدين-3- كربوكساميد واسترجاع (4s)-4-(4- سيانو-2- ميثوكسي فنيل)-5- إيثوكسي-8،2- داي ميثيل-4،1- داي هيدرو-6،1- نافثيريدين-3- كربوكساميد بواسطة طرق كهروكيميائية | |
SA515361251B1 (ar) | طريقة لزيادة تكوين حمض بيرو-جلوتاميك من بروتين | |
WO2013121436A3 (en) | A process for preparation of rivaroxaban and intermediates thereof | |
MX2014014138A (es) | Procedimiento nuevo para la preparacion de acido 2-ciclopentil-6-metoxi-isonicotinico. | |
EP2548949A4 (en) | MICROORGANISM WITH IMPROVED PRODUCTION OF 5'-XANTHOSINE MONOPHOSPHATE AND 5'-GUANINE MONOPHOSPHATE AND PRODUCTION PROCESS FOR 5'-XANTHOSINE MONOPHOSPHATE AND 5'-GUANINE MONOPHOSPHATE THEREWITH | |
IN2015KN00323A (enrdf_load_html_response) | ||
DK3342867T3 (da) | Xylanasemutant, fremgangsmåde til fremstilling og anvendelse herfor, og fremgangsmåde til fremstilling af forsukret lignocellulose | |
EP2463266A4 (en) | PROCESS FOR PRODUCING BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE | |
GB2533072A (en) | Biomass processing method | |
MY155284A (en) | Process for the preparation of ajoene | |
UA102865C2 (ru) | Вспомогательные вещества для таблетирования на основе лактозы и целлюлозы | |
UA106724C2 (uk) | Спосіб отримання заміщених піримідинових похідних | |
WO2008015703A3 (en) | Process for the preparation of montelukast and its salts thereof | |
MY163020A (en) | A process for the preparation of etoricoxib | |
MX2010009931A (es) | Proceso para la preparacion de 2-amino-2-[2-(4-c3-c21-alquil-fenil )-etil]-propano-1,3-dioles. | |
MX379125B (es) | Métodos para producir molindona y sus sales. | |
MX2013006017A (es) | Separacion de enantiomeros derivados de triazina usando acido tartarico. | |
MX2014004847A (es) | Procedimiento para la preparacion y estabilizacion de composiciones de policarbonato modificadas al impacto usando disoluciones diluidas de compuestos acidos. | |
MX349985B (es) | Procedimiento de preparación de ésteres de fenilacetil aminoácido espirocíclicos con sustitución cis-alcoxi y derivados de 1h-pirrolidin-2,4-diona espirocicíclicos con sustitución cis-alcoxi. | |
EA201101613A1 (ru) | Способ получения севеламера | |
SA517390540B1 (ar) | عملية لتحضير سيانيد الصوديوم |